Chandelier
Senior Member (Voting Rights)
1000-word article in The Washington Post:
HHV-6B reactivation is already quite well understood from the research into the problem in immuno-suppressed patients. So there is no need to reinvent the wheel.Jo Cambridge and I have shared various projects with Jackie C and I think her studies are very interesting. But if we all have HHV6 to reactivate then the 'cause' we are looking for would need to be something that makes HHV6 reactivate in people with ME/CFS rather than the rest of us. And the problem is that HHV6 reactivation might just be an epiphenomenal sign of some more general regulatory issue. The task is then to find what the upstream problem is.
HHV-6B reactivation is already quite well understood from the research into the problem in immuno-suppressed patients. So there is no need to reinvent the wheel.
I don't follow. Since we have no evidence for 'immuno-suppression' in ME/CFS presumably we do have to find another explanation. (Large numbers of studies of ME/CFS have found immune cell populations and behaviour to be normal, with maybe some cells showing a bit more activation. There were some papers claiming defects in NK cells but even the original authors had trouble replicating those. Jackie could not replicate any NK defect.)
In Buddhism we have a saying that goes along the lines of: A beginner's mind has a lot of possibilities whereas an expert's hasn't.
Thread here:Meta-analysis of natural killer cell cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome - PMC
Reduced natural killer (NK) cell cytotoxicity is the most consistent immune finding in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Meta-analysis of the published literature determined the effect size of the decrement in ME/CFS. ...pmc.ncbi.nlm.nih.gov